Epiminder Ltd (EPI) - Total Assets
Based on the latest financial reports, Epiminder Ltd (EPI) holds total assets worth AU$104.35 Million AUD (≈ $73.84 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how efficiently does Epiminder Ltd generate cash for how efficiently the company converts equity into cash flow.
Epiminder Ltd - Total Assets Trend (2023–2025)
This chart illustrates how Epiminder Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Epiminder Ltd for real-time trading data and today's change.
Epiminder Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Epiminder Ltd's total assets of AU$104.35 Million consist of 89.9% current assets and 10.1% non-current assets. Explore EPI current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 89.5% |
| Accounts Receivable | AU$383.33K | 0.3% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$70.57K | 0.1% |
| Intangible Assets | AU$13.15 Million | 10.1% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how Epiminder Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Epiminder Ltd's current assets represent 89.9% of total assets in 2025, an increase from 54.6% in 2023.
- Cash Position: Cash and equivalents constituted 89.5% of total assets in 2025, up from 30.5% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 45.0% in 2023.
- Asset Diversification: The largest asset category is intangible assets at 10.1% of total assets.
Epiminder Ltd Competitors by Total Assets
Key competitors of Epiminder Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.81 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Brainsway Ltd
NASDAQ:BWAY
|
USA | $121.97 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
Epiminder Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 23.21 | - | - |
| Quick Ratio | 23.21 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | AU$87.21 Million | - | - |
Epiminder Ltd - Advanced Valuation Insights
This section examines the relationship between Epiminder Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.00 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 282.3% |
| Total Assets | AU$130.71 Million |
| Market Capitalization | $45.23K USD |
Valuation Analysis
Below Book Valuation: The market values Epiminder Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Epiminder Ltd's assets grew by 282.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Epiminder Ltd (2023–2025)
The table below shows the annual total assets of Epiminder Ltd from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$130.71 Million ≈ $92.48 Million |
+282.27% |
| 2024-06-30 | AU$34.19 Million ≈ $24.19 Million |
-6.52% |
| 2023-06-30 | AU$36.58 Million ≈ $25.88 Million |
-- |
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more